Abstract:The specific binding peptide pd20 of gastric cancer cells with a high potential for liver metastasis was fused with human tumour necrosis factor (TNF) α, and a prokaryotic expression vector was established to express the pd20–TNFα fusion protein. After purification and identification, the preventive effects of the fusion protein on liver metastasis of gastric cancer were observed in mice. The whole gene synthesis method was used for pd20–TNFα fusion gene preparation, and a pd20–TNFα prokaryotic expression vector was constructed. The vector was induced and expressed in Escherichia coli BL21. The expression products were analysed and verified by SDS-PAGE electrophoresis and Western blot analysis. The Ni-NTA column method was used to purify the fusion protein, and the L929 cytotoxicity method was used to detect biological activity. Flow cytometry apoptosis experiments and invasion assays were performed to observe the effects of the fusion protein on apoptosis and metastasis of gastric cancer cells with high potential for liver metastasis. Thirty nude mice with liver metastasis of gastric cancer were established and then randomly divided into three groups of ten mice each. The Pd20–TNFα recombinant protein (1.2 × 10 6 U/kg day) or standard TNFα (1.2 × 10 6 U/kg day) saline was administered via tail vein injection for 7 consecutive days. The pathological changes in various organs of nude mice were observed 4 weeks later. The size of the gastric cancer, the incidence of liver metastasis and the number of liver metastases were measured and calculated. We successfully constructed a Pd20–TNFα recombinant plasmid and prepared the fusion protein. Detection of the pd20–TNFα protein by immunofluorescence showed a very strong expression in liver tissue, suggesting a targeting of the fusion protein to the liver. The L929 cytotoxicity assays showed that the pd20–TNFα fusion purified protein had a significant lethal effect on L929 cells, with a killing activity of up to 7.6 × 10 6 IU/ml. The apoptosis experiments showed that as the concentration of the fusion protein increased, the early gastric cancer cell apoptosis also increased, with the early apoptosis rate increasing from 5.99 % to 9.04 %. Cell invasion experiments showed that the purified pd20–TNFα fusion protein significantly inhibited the in vitro invasion of XGC9811-L cells, with the penetrating cells being significantly decreased compared with the control group per unit time ( P < 0.01). Vector experiments showed that the pd20–TNFα recombinant protein group had significantly reduced cancer lesions and liver metastasis in nude mice compared with the control group. We successfully purified a pd20–TNFα fusion protein and confirmed that it had significant biological activity promoting early gastric cancer cell apoptosis, thereby inhibiting gastric cancer cell invasion.

Expression and purification of a putative tumor suppressor gene PP5715 in E. coli with growth inhibition of hepatocellular carcinoma cells

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

[Expression and Function of Hepatocellular Carcinoma-Related Gene Pp1158].

Molecular cloning and characterization of PP3105, a novel cell growth-related gene

Expression,purification and Transduction of PTD-p53 Fusion Protein to Hepatocellular Carcinoma Cell

Identification of Carboxypeptidase of Glutamate Like-B As a Candidate Suppressor in Cell Growth and Metastasis in Human Hepatocellular Carcinoma.

Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma

Purification of a Pd20–TNFα Fusion Protein That Prevents Liver Metastasis of Gastric Cancer

HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein.

Expression, Purification, and Breast Cancer Cell Inhibiting Effect of Recombinant Human Lactoferrin C-Lobe

Characterization of Recombinant Toxin rCCK96-104PE38 Targeting Colon Cancer

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].

Differential Expression and Preliminary Function Study of Novel Tumor Related Gene Pp4519

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation

[Expression, Purification and Transduction of Tat-p53 Fusion Protein].

Tumor Suppressor LHPP Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cell Lines.

MT1G Serves As a Tumor Suppressor in Hepatocellular Carcinoma by Interacting with P53

Expression of Curcin-Transferrin Receptor Binding Peptide Fusion Protein and Its Anti-Tumor Activity.

Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.

Expression and Function of CL-L1 in Hepatocellular Carcinoma

Long Noncoding Rna Tp53tg1 Suppresses The Growth And Metastasis Of Hepatocellular Carcinoma By Regulating The Prdx4/Beta-Catenin Pathway